Aaron Rupar Stunned What Donald Trump Said About Lifelong Devout Catholic Joe Biden
NBC News Reports That President Biden Has Grown Angry About Re-Election Effort
The New Yorker Describes the 'Repressive, Authoritarian Soul' of 'Thomas the Tank Engine'...
Washington Post Writer Back With Another Hot Take on Whiteness and Country Radio
Color Us COMPLETELY Unsurprised: LAPD Task Force Created to Deal with Gangs of...
Media Matters Ari Drennen Plays Stupid, Claims You Need A DNA Test to...
New York Times Reports That 'Raunchy Christians' Are Turning Toward the Risqué
Best Economy Ever, Jack! More Americans Dip Into Retirement Savings to Make Ends...
Democrats Again Defending Dignity of MS-13 Gang Members
WATCH: Video of Nashville PD Physical Fitness Test Is MAJOR Cringe
Sen. Brian Schatz Tells Headline Writers How to Take Donald Trump Quote Out...
SHOCKING NEWS: New Study Reports Woke People Are Likely to Be Depressed and...
It's a Bloodbath (Hoax) Out There!
CNN Obviously Has No Problem With 'Bloodbath' When THEY Use the Word
Justice Ketanji Brown Jackson Concerned First Amendment Hamstrings Government

HHS explains purchase of $290 million worth of 'drug for use in radiological and nuclear emergencies'

The Department of Health & Human Services’ Administration for Strategic Preparedness & Response now has a statement on a web page about a recent $290 million purchase. Perhaps this kind of thing is fairly routine (the program started in 2004) but considering what’s going on in the world this has caught some attention:

Advertisement

Hey, you can never be too careful in the “Build Back Better” era now that America is so much more respected on the world stage!

From the ASPR’s section of the HHS’s website:

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

Amgen, based in Thousands Oaks, California, developed Nplate for ARS with support from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), as well as the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.

Advertisement

Some skepticism has ensued:


https://twitter.com/SojournerMrs/status/1577781523809505280

You know what’s coming next:

It’s going to be so important that any future nuclear war is kept as “equitable” as possible.
***

Related:

HHS Secretary Xavier Becerra says his department is continuing to explore opening abortion clinics on federal land

HHS Secretary Xavier Becerra supports government funding of gender affirming surgeries on minors

***

Editor’s Note:

Help us keep owning the libs! Join Twitchy VIP and use promo code AMERICAFIRST to receive a 25% discount off your membership!

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement